ECSP972233A - DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO - Google Patents
DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICOInfo
- Publication number
- ECSP972233A ECSP972233A ECSP972233A ECSP972233A EC SP972233 A ECSP972233 A EC SP972233A EC SP972233 A ECSP972233 A EC SP972233A EC SP972233 A ECSP972233 A EC SP972233A
- Authority
- EC
- Ecuador
- Prior art keywords
- diseases
- involve
- production
- cancer
- hidroxamico
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 abstract 2
- 102100040247 Tumor necrosis factor Human genes 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 etopoxide Chemical compound 0.000 abstract 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 2
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 abstract 1
- 208000030507 AIDS Diseases 0.000 abstract 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 abstract 1
- 206010014989 Epidermolysis bullosa Diseases 0.000 abstract 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 1
- 206010029333 Neurosis Diseases 0.000 abstract 1
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- 206010040047 Sepsis Diseases 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 229940009456 adriamycin Drugs 0.000 abstract 1
- 229930013930 alkaloid Natural products 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 abstract 1
- 229960004316 cisplatin Drugs 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
- 208000015238 neurotic disease Diseases 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- 229940124641 pain reliever Drugs 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
- 230000036269 ulceration Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un compuesto de la fórmula (gráfico), en la que n, X, R1, R1 y Q son como se han definido anteriormente útil en el tratamiento de un trastorno seleccionado entre el grupo formado por artritis, cáncer, ulceración de tejidos, degeneración macular, reestemosis, enfermedad periodontal, epidermólisis ampollosa, esclenitis y otras enfermedades caracterizadas por actividad de metaloproteinasa matriciales, SIDA, sepsis, choque séptico y otras enfermedades que implican la producción de factor de necrosis tumoral enfermedades que implican la producción de factor de neurosis tumoral (TNF). Además, los compuestos de la presente invención se pueden usar en terapia de combinación con fármacos antiinflamatorios no esteroides (AINE) y analgésicos convencionales y junto con fármacos citotóxicos como adriamicina, daunomicina, cisplatino, etopóxido, taxol, taxóteroy otros alcaloides como vineristina, en el tratamiento de cáncer.A compound of the formula (graph), wherein n, X, R1, R1 and Q are as defined above useful in the treatment of a disorder selected from the group consisting of arthritis, cancer, tissue ulceration, macular degeneration , rheosmosis, periodontal disease, epidermolysis bullosa, sclenitis and other diseases characterized by matrix metalloproteinase activity, AIDS, sepsis, septic shock and other diseases that involve the production of tumor necrosis factor, diseases that involve the production of tumor neurosis factor (TNF ). Furthermore, the compounds of the present invention can be used in combination therapy with non-steroidal anti-inflammatory drugs (NSAIDs) and conventional pain relievers, and together with cytotoxic drugs such as adriamycin, daunomycin, cisplatin, etopoxide, taxol, taxatero, and other alkaloids such as vineristine, in the cancer treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972233 ECSP972233A (en) | 1997-08-22 | 1997-08-22 | DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972233 ECSP972233A (en) | 1997-08-22 | 1997-08-22 | DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972233A true ECSP972233A (en) | 1998-09-22 |
Family
ID=42043064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972233 ECSP972233A (en) | 1997-08-22 | 1997-08-22 | DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972233A (en) |
-
1997
- 1997-08-22 EC ECSP972233 patent/ECSP972233A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR009292A1 (en) | DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO, PROCESSES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT | |
| AR011056A1 (en) | SULPHONE-DERIVED COMPOUND AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| CO4890852A1 (en) | MATRICIAL METALOPROTEASE INHIBITORS BASED ON PHOSPHYTES | |
| PA8446101A1 (en) | ARILSULFONIL HYDROXAMIC ACID DERIVATIVES | |
| BR9807815A (en) | Arylsulfonylamino-hydroxamic acid derivatives | |
| AR019241A1 (en) | DERIVATIVES OF HYDROXAMIC HYDROXAMIC ACID, COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE OF TREATMENT OF ARTHRITIS, CANCER AND OTHER DISEASES. | |
| ES2178724T3 (en) | ARILSULFONAMIDE ALPHA-SUBSTITUTED HYDROXAMIC ACIDS AS INHIBITORS OF ALFA TUMOR NECROSIS FACTOR AND MATRIX METALOPROTEINASES. | |
| CO4700432A1 (en) | DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXALICO | |
| UY25992A1 (en) | PROCEDURE FOR PREPARING TACE INHIBITORS (TUMOR NECROSIS ALPHA FACTOR CONVERSING ENZYME) | |
| PA8456801A1 (en) | DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS | |
| ES2153031T3 (en) | ARILSULFONIL HYDROXAMIC ACID DERIVATIVES AS INHIBITORS OF MMP AND TNF. | |
| ECSP972233A (en) | DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO | |
| ECSP982358A (en) | CYCLE DERIVATIVES OF SULFONA | |
| ECSP982404A (en) | ARILSULFONIL HYDROXAMIC ACID DERIVATIVES | |
| ECSP982394A (en) | ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES | |
| ECSP972193A (en) | PHOSPHINATE BASED MATRIO METALOPROTEASE INHIBITORS | |
| ECSP993100A (en) | HYDROXY ACID DERIVATIVES - HYDROXAMIC PIPECOLATE | |
| ECSP993099A (en) | TACE INHIBITORS | |
| ECSP961719A (en) | DERIVATIVES OF ACID ARIL SULFONIL HIDROXAMICO | |
| ECSP961684A (en) | DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO | |
| GT199800003A (en) | CYCLE DERIVATIVES OF SULFONA |